Awakn Life Sciences (XCNQ:AWKN) Beneish M-Score : -47.23 (As of Mar. 28, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -47.23 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Awakn Life Sciences's Beneish M-Score or its related term are showing as below:

XCNQ:AWKN' s Beneish M-Score Range Over the Past 10 Years
Min: -150.34 Med: -28.68 Max: 32.33
Current: -47.23

During the past 4 years, the highest Beneish M-Score of Awakn Life Sciences was 32.33. The lowest was -150.34. And the median was -28.68.

Awakn Life Sciences Beneish M-Score Historical Data

The historical data trend for Awakn Life Sciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Beneish M-Score Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Beneish M-Score

-8.50

-27.23

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Beneish M-Score	Get a 7-Day Free Trial											-32.35	-27.23	-150.34	-30.12	-47.23

Competitive Comparison of Awakn Life Sciences's Beneish M-Score

For the Biotechnology subindustry, Awakn Life Sciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Awakn Life Sciences's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Beneish M-Score falls into.

Save Embed

;

Save Embed

;

Awakn Life Sciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Awakn Life Sciences for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.2355

0.528 * -12.5909

0.404 * 1.0552

0.892 * 0.8788

0.115 * 0.9444

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.54

4.679 * -7.825112

0.327 * 1.7532

-47.23

This Year (Oct24) TTM:

Last Year (Oct23) TTM:

Total Receivables was C$0.07 Mil.
Revenue was 0.004 + 0.011 + 0.021 + 0.022 = C$0.06 Mil.
Gross Profit was 0.004 + 0.011 + 0.021 + 0.022 = C$0.06 Mil.
Total Current Assets was C$0.64 Mil.
Total Assets was C$0.67 Mil.
Property, Plant and Equipment(Net PPE) was C$0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was C$0.02 Mil.
Selling, General, & Admin. Expense(SGA) was C$1.73 Mil.
Total Current Liabilities was C$2.19 Mil.
Long-Term Debt & Capital Lease Obligation was C$0.00 Mil.
Net Income was -0.376 + -0.361 + -0.545 + -1.116 = C$-2.40 Mil.
Non Operating Income was 0.096 + 0.221 + -0.021 + -0.477 = C$-0.18 Mil.
Cash Flow from Operations was -0.595 + 0.003 + -0.501 + 4.111 = C$3.02 Mil.

Total Receivables was C$0.34 Mil.
Revenue was 0.029 + 0.025 + 0.012 + 0 = C$0.07 Mil.
Gross Profit was 0.029 + 0.025 + -0.43 + -0.455 = C$-0.83 Mil.
Total Current Assets was C$1.04 Mil.
Total Assets was C$1.09 Mil.
Property, Plant and Equipment(Net PPE) was C$0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was C$0.02 Mil.
Selling, General, & Admin. Expense(SGA) was C$3.64 Mil.
Total Current Liabilities was C$2.04 Mil.
Long-Term Debt & Capital Lease Obligation was C$0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.071 / 0.058)	/	(0.343 / 0.066)
	=	1.224138	/	5.19697
	=	0.2355

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(-0.831 / 0.066)	/	(0.058 / 0.058)
	=	-12.590909	/	1
	=	-12.5909

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0.636 + 0) / 0.669)	/	(1 - (1.039 + 0.001) / 1.091)
	=	0.049327	/	0.046746
	=	1.0552

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.058	/	0.066
	=	0.8788

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.017 / (0.017 + 0.001))	/	(0.019 / (0.019 + 0))
	=	0.944444	/	1
	=	0.9444

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.727 / 0.058)	/	(3.639 / 0.066)
	=	29.775862	/	55.136364
	=	0.54

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 2.192) / 0.669)	/	((0 + 2.039) / 1.091)
	=	3.276532	/	1.868928
	=	1.7532

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-2.398 - -0.181	-	3.018)	/	0.669
	=	-7.825112

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Awakn Life Sciences has a M-score of -47.23 suggests that the company is unlikely to be a manipulator.

Awakn Life Sciences Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines